TRINITY
Live / Allowed — Published for opposition (as of 10 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 12 Apr 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98498390
- Mark type
- Stylized text
- Filed
- 12 Apr 2024
- Published for opposition
- 10 Mar 2026
- Attorney of record
- Samantha C. Markley
Goods and services
- Class 001 — Chemicals: Assays and reagents for use in genetic research; diagnostic reagents for scientific or research use; diagnostic reagents for clinical or medical laboratory use, other than for medical or veterinary purposes; reagents and reagent kits, other than for medical or veterinary purposes, comprised primarily of nucleic acids, naturally occurring or modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression for scientific research use, for diagnostic scientific use, and for clinical laboratory research use; clinical diagnostic reagents for laboratory use, other than for medical or veterinary purposes; reagent kits and reagent beads, other than for medical or veterinary purposes, with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for clinical diagnostic laboratory purposes
- Class 005 — Pharmaceuticals: Medical diagnostic reagents; clinical medical diagnostic reagents; reagent kits and reagent beads with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for clinical medical diagnostic purposes; reagents and reagent kits comprised primarily of nucleic acids, naturally occurring or modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression for diagnostic medical use and for clinical medical use; diagnostic reagents for clinical or medical laboratory use, for medical or veterinary purposes; reagents and reagent kits, for medical or veterinary purposes, comprised primarily of nucleic acids, naturally occurring or modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression for clinical laboratory research use; clinical diagnostic reagents for laboratory use, for medical or veterinary purposes; reagent kits and reagent beads, for medical or veterinary purposes, with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for clinical diagnostic laboratory purposes
- Class 009 — Scientific and electric apparatus: Computer systems, namely, computer hardware, downloadable and recorded computer software and associated downloadable data files for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; downloadable and recorded computer software for data collection, management, and analysis of genetic information for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; clinical diagnostic instruments for scientific use, namely, nucleic acid sequencers, imaging devices for nucleic acids and biological molecules and analyzers in the nature of scientific laboratory research instruments for DNA analysis
- Class 010 — Medical apparatus: Clinical diagnostic instruments for medical use, namely, nucleic acid sequencers, imaging devices for biomolecules and analyzers in the nature of flow-based analyzers providing cell and particle analysis, detection, or counting
- Class 042 — Scientific and technological services: Providing reagent sample diagnostic testing services for others for scientific research purposes and scientific research related thereto; clinical diagnostic services for scientific research purposes, namely, preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids from human beings; providing online non-downloadable computer software for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; providing online non-downloadable computer software for data collection, management, and analysis of genetic information for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes
Owner
- Element Biosciences, Inc., San Diego, CA, US
- Element Biosciences, Inc., San Diego, CA, US
Prosecution history
- 10 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Mar 2026 — PUBLISHED FOR OPPOSITION
- 04 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 09 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 09 Feb 2026 — ASSIGNED TO LIE
- 02 Feb 2026 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 02 Oct 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 02 Oct 2025 — LETTER OF SUSPENSION E-MAILED
- 02 Oct 2025 — SUSPENSION LETTER WRITTEN
- 14 Aug 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 14 Aug 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 14 Aug 2025 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 07 May 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED